ADVFN - Advanced Financial Network.
HOME» NASDAQ » H » HGSI Stock Price » HGSI Stock News

Human Genome Sciences Share News

 Human Genome Sciences (mm) Stock Price
HGSI Stock Price
 Human Genome Sciences (mm) Stock Chart
HGSI Stock Chart
 Human Genome Sciences (mm) Stock News
HGSI Stock News
 Human Genome Sciences (mm) Company Information
HGSI Company Information
 Human Genome Sciences (mm) Stock Trades
HGSI Stock Trades

GlaxoSmithKline Confirms Rejected $13/Share Approach To Human Genome

LONDON -(Dow Jones)- GlaxoSmithKline PLC (GSK.LN) confirmed Thursday that it made an offer to the board of Human Genome Sciences (HGSI) on April 11 proposing to buy the outstanding shares of Human Genome for $13 each in cash, but said the offer has been rejected without discussion. MAIN FACTS: -GlaxoSmithKline believes the acquisition can be completed expeditiously and is prepared to start a cash tender offer with no financing or due diligence condition. -Offer represented a 81% premium to Human Genome's closing share price Wednesday. -Through complete ownership, GlaxoSmithKline can simplify and optimize R&D, commercial and manufacturing operations to advance these products most effectively and efficiently while securing the full potential long-term value of the assets. -GlaxoSmithKline expects to achieve at least $200 million in cost synergies to be fully realized by 2015 and expect the transaction to be earnings-accretive beginning in 2013. -GlaxoSmithKline has also assessed the potential returns of this acquisition relative to its long-term share buyback program. -As part of this ongoing program, GlaxoSmithKline continues to expect to repurchase GBP1 billion to 2 billion in shares in 2012. -GlaxoSmithKline shares at 1153 GMT up 17 pence or 1.1%, at GBP14.58, valuing the company at GBP72.69 billion. -By Razak Musah Baba, Dow Jones Newswires; 44-20-7842-9275;

Stock News for Human Genome Sciences (HGSI)
No Recent News Available

Human Genome Sciences and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations